To our knowledge, this is the first study reporting co-occurrences of MYC/STK11 and MYC/ERBB2 and were preliminarily confirmed as statistically significant in the TCGA pan-lung cancer cohort (43). The gene discussed is MYC; the disease is lung carcinoma.